European Primary Care Cardiovascular Society (EPCCS) consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care

Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation

(2014) R. G. Tieleman et al.   EUROPACE

Is screening for AF worthwhile? Stroke risk in a screened population from the SAFE study

(2014) D A Fitzmaurice et al.   FAMILY PRACTICE

Comparative Effectiveness of Warfarin and New Oral Anticoagulants for the Management of Atrial Fibrillation and Venous Thromboembolism

(2013) Soheir S. Adam et al.   ANNALS OF INTERNAL MEDICINE

A specific antidote for dabigatran: functional and structural characterization

(2013) F. Schiele et al.   BLOOD

Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin

(2013) Ammar Majeed et al.   CIRCULATION

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

(2013) Hein Heidbuchel et al.   EUROPACE

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa

(2013) Genmin Lu et al.   NATURE MEDICINE

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel Oral Anticoagulants

(2013) Charalampos Kasmeridis et al.   PHARMACOECONOMICS

Predictive Value of the HAS-BLED and ATRIA Bleeding Scores for the Risk of Serious Bleeding in a “Real-World” Population With Atrial Fibrillation Receiving Anticoagulant Therapy

(2012) Vanessa Roldán et al.   CHEST

Newer Oral Anticoagulants Should Be Used as First-Line Agents to Prevent Thromboembolism in Patients With Atrial Fibrillation and Risk Factors for Stroke or Thromboembolism

(2012) Christopher B. Granger et al.   CIRCULATION

Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation

(2012) Pilar Gallego et al.   Circulation-Arrhythmia and Electrophysiology

Assessing the Risk of Bleeding in Patients With Atrial Fibrillation

(2012) Gregory Y. H. Lip et al.   Circulation-Arrhythmia and Electrophysiology

Reliable Identification of “Truly Low” Thromboembolic Risk in Patients Initially Diagnosed With “Lone” Atrial Fibrillation

(2012) Tatjana S. Potpara et al.   Circulation-Arrhythmia and Electrophysiology

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

(2012) Leif Friberg et al.   EUROPEAN HEART JOURNAL

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPEAN HEART JOURNAL

Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study

(2012) Karen Barnett et al.   LANCET

Subclinical Atrial Fibrillation and the Risk of Stroke

(2012) Jeff S. Healey et al.   NEW ENGLAND JOURNAL OF MEDICINE

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

(2011) Valentin Fuster et al.   CIRCULATION

Comparison of the reliability and validity of four contemporary risk stratification schemes to predict thromboembolism in non-anticoagulated patients with atrial fibrillation

(2011) E. Abu-Assi et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Bleeding risk in ‘real world’ patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort

(2011) J. B. OLESEN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Excessive Supraventricular Ectopic Activity and Increased Risk of Atrial Fibrillation and Stroke

(2010) Zeynep Binici et al.   CIRCULATION

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPEAN HEART JOURNAL

Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation

(2010) Gregory Y.H. Lip et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice

(2010) T. P. VAN STAA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

(2010) Lars Wallentin et al.   LANCET

Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation

(2009) L. Friberg et al.   EUROPEAN HEART JOURNAL

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation

(2009) Carl van Walraven et al.   STROKE

Heart Disease and Stroke Statistics—2008 Update

(2007) et al.   CIRCULATION